last data update: 2011/10/14, 20:38
Website loading time
during the test: 0.44 s
cable connection (average): 0.59 s
DSL connection (average): 0.73 s
modem (average): 8.4 s
HTTP headers
HTTP/1.1 301 Moved Permanently
Server: Apache/2.2.3 (Red Hat)
Location: http://www.fiercepharma.com/
Cache-Control: max-age=1
Expires: Sat, 15 Oct 2011 03:38:36 GMT
Content-Type: text/html; charset=iso-8859-1
Content-Length: 318
Date: Sat, 15 Oct 2011 03:38:36 GMT
X-Varnish: 1229364624 1229364607
Age: 1
Via: 1.1 varnish
Connection: close
HTTP/1.1 200 OK
Server: Apache/2.2.3 (Red Hat)
X-Powered-By: PHP/5.2.17
X-Drupal-Cache: HIT
Etag: "1318648894-0"
X-UA-Compatible: IE=8
Last-Modified: Sat, 15 Oct 2011 03:21:34 +0000
Vary: Cookie,Accept-Encoding
Content-Type: text/html; charset=utf-8
Cache-Control: max-age=60
Content-Length: 57088
Date: Sat, 15 Oct 2011 03:38:36 GMT
X-Varnish: 1229364629 1229364609
Age: 1
Via: 1.1 varnish
Connection: close
Information about DNS servers
fiercepharma.com | A | 74.205.46.249 | IN | 21027 | |
fiercepharma.com | NS | ns0.dnsmadeeasy.com | IN | 42627 | |
fiercepharma.com | NS | ns2.dnsmadeeasy.com | IN | 42627 | |
fiercepharma.com | NS | ns3.dnsmadeeasy.com | IN | 42627 | |
fiercepharma.com | NS | ns4.dnsmadeeasy.com | IN | 42627 | |
fiercepharma.com | NS | ns1.dnsmadeeasy.com | IN | 42627 |
Received from the first DNS server
Request to the server "fiercepharma.com"
You used the following DNS server:
DNS Name: ns0.dnsmadeeasy.com
DNS Server Address: 208.94.148.2#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 34970
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 2
REQUEST SECTION:
fiercepharma.com. IN ANY
ANSWER SECTION:
fiercepharma.com. 86400 IN NS ns3.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns4.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns2.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns1.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns0.dnsmadeeasy.com.
fiercepharma.com. 21600 IN A 74.205.46.249
fiercepharma.com. 21600 IN MX 10 aspmx5.googlemail.com.
fiercepharma.com. 21600 IN MX 1 aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt1.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt2.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 10 mail.fiercepharma.com.
fiercepharma.com. 21600 IN MX 10 aspmx2.googlemail.com.
fiercepharma.com. 86400 IN TXT "v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -all"
fiercepharma.com. 86400 IN SOA ns0.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2006010137 43200 3600 1209600 180
SECTION NOTES:
mail.fiercepharma.com. 21600 IN A 74.205.124.101
mail.fiercepharma.com. 21600 IN A 72.3.226.221
Received 458 bytes from address 208.94.148.2#53 in 14 ms
Received from the second DNS server
Request to the server "fiercepharma.com"
You used the following DNS server:
DNS Name: ns2.dnsmadeeasy.com
DNS Server Address: 208.80.126.2#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 48470
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 2
REQUEST SECTION:
fiercepharma.com. IN ANY
ANSWER SECTION:
fiercepharma.com. 86400 IN NS ns3.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns4.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns2.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns1.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns0.dnsmadeeasy.com.
fiercepharma.com. 21600 IN A 74.205.46.249
fiercepharma.com. 21600 IN MX 10 aspmx2.googlemail.com.
fiercepharma.com. 21600 IN MX 10 aspmx5.googlemail.com.
fiercepharma.com. 21600 IN MX 1 aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt1.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt2.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 10 mail.fiercepharma.com.
fiercepharma.com. 86400 IN TXT "v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -all"
fiercepharma.com. 86400 IN SOA ns0.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2006010137 43200 3600 1209600 180
SECTION NOTES:
mail.fiercepharma.com. 21600 IN A 72.3.226.221
mail.fiercepharma.com. 21600 IN A 74.205.124.101
Received 458 bytes from address 208.80.126.2#53 in 13 ms
Subdomains (the first 50)
Typos (misspells)
diercepharma.com ciercepharma.com viercepharma.com giercepharma.com tiercepharma.com riercepharma.com fuercepharma.com fjercepharma.com fkercepharma.com foercepharma.com f9ercepharma.com f8ercepharma.com fiwrcepharma.com fisrcepharma.com fidrcepharma.com firrcepharma.com fi4rcepharma.com fi3rcepharma.com fieecepharma.com fiedcepharma.com fiefcepharma.com fietcepharma.com fie5cepharma.com fie4cepharma.com fierxepharma.com fiervepharma.com fierfepharma.com fierdepharma.com fiercwpharma.com fiercspharma.com fiercdpharma.com fiercrpharma.com | fierc4pharma.com fierc3pharma.com fierceoharma.com fiercelharma.com fierce-harma.com fierce0harma.com fiercepgarma.com fiercepbarma.com fiercepnarma.com fiercepjarma.com fiercepuarma.com fiercepyarma.com fiercephzrma.com fiercephsrma.com fiercephwrma.com fiercephqrma.com fiercephaema.com fiercephadma.com fiercephafma.com fiercephatma.com fiercepha5ma.com fiercepha4ma.com fiercepharna.com fiercepharka.com fiercepharja.com fiercepharmz.com fiercepharms.com fiercepharmw.com fiercepharmq.com iercepharma.com fercepharma.com fircepharma.com | fiecepharma.com fierepharma.com fiercpharma.com fierceharma.com fierceparma.com fiercephrma.com fiercephama.com fiercephara.com fiercepharm.com ifercepharma.com feircepharma.com firecepharma.com fiecrepharma.com fierecpharma.com fiercpeharma.com fiercehparma.com fiercepahrma.com fiercephrama.com fiercephamra.com fiercepharam.com ffiercepharma.com fiiercepharma.com fieercepharma.com fierrcepharma.com fierccepharma.com fierceepharma.com fierceppharma.com fiercephharma.com fiercephaarma.com fiercepharrma.com fiercepharmma.com fiercepharmaa.com |
Location
IP: 74.205.46.249
continent: NA, country: United States (USA), city: Washington
Website value
rank in the traffic statistics:
There is not enough data to estimate website value.
Basic information
website build using CSS
code weight: 55.75 KB
text per all code ratio: 10 %
title: Pharma News, Pharma Industry, Pharmaceuticals Industry --- Fierce Pharma
description: Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
keywords: Pharmaceutical News, Pharma News, Pharma Industry, Pharmaceutical Industry News, Pharma, Pharma Company, Pharmaceutical Company, FDA regulation, FDA news, Big Pharma, Pharmaceutical Marketing, Pharmaceutical Contract Manufacturing, Pharmaceutical Industry
encoding: utf-8
language: en
Website code analysis
one word phrases repeated minimum three times
Phrase | Quantity |
---|---|
Clinical | 4 |
Research | 4 |
Job | 3 |
Events | 3 |
Drug | 3 |
Celgene | 3 |
Corporation | 3 |
US | 3 |
NJ, | 3 |
Development | 3 |
Jobs | 3 |
Pharma | 3 |
>> | 3 |
two word phrases repeated minimum three times
Phrase | Quantity |
---|---|
Job Celgene | 3 |
Celgene Corporation | 3 |
NJ, US | 3 |
three word phrases repeated minimum three times
Phrase | Quantity |
---|---|
Job Celgene Corporation | 3 |
B tags
U tags
I tags
images
file name | alternative text |
---|---|
fp_logo.gif?12 | |
fbtabs_02.gif | FierceBiotech |
fbtabs_03.gif | FierceBiotech IT |
fbtabs_04-sel.gif | FiercePharma |
fbtabs_05.gif | FierceMedicalDevices |
fbtabs_06.gif | FierceBiotech Research |
fbtabs_07.gif | FierceVaccines |
fbtabs_08.gif | FiercePharma Manufacturing |
fbtabs_09.gif | FierceDrugDelivery |
feed.png | Syndicate content |
tweet.gif | Clicky |
alert1.jpg | |
pillpackets.jpg | |
xraypiggy2.jpg | |
fmtrans.gif | |
?pid=639&fmt=gif | |
66488011-db4.gif |
headers
H1
Latest News
H2
Free Newsletter
Hottest Products
Featured Jobs
Popular Topics
Events
Latest News
Also Noted
Press Releases
Popular Comment Threads
Special Report
News
Whitepapers
Paid Research Reports
H3
Free Newsletter
Hottest Products
Featured Jobs
Popular Topics
Events
Latest News
Also Noted
Press Releases
Popular Comment Threads
Special Report
News
Whitepapers
Paid Research Reports
H4
H5
H6
internal links
address | anchor text |
---|---|
/ | |
/help | Help |
/ | Home |
/news | News |
/signup?sourceform=Organic-Web_aboutlink-fiercepharma-fiercepharma | About |
/sample | View Sample |
/privacy | Privacy |
/tags/pfizer | Pfizer |
/tags/glaxosmithkline | GlaxoSmithKline |
/tags/merck | Merck |
/tags/fda | FDA |
/tags/eli-lilly | Eli Lilly |
/tags/astrazeneca | AstraZeneca |
/tags/novartis | Novartis |
/tags/drug-safety | drug safety |
/tags/roche | Roche |
/tags/fda-approval | FDA approval |
/tags/johnson-johnson | Johnson & Johnson |
/tags/sanofi-aventis | Sanofi-Aventis |
/tags/amgen | Amgen |
/tags/pharmaceutical-layoffs | pharmaceutical layoffs |
/tags | More tags... |
/signup?sourceform=Organic-Web_aboutlink-fiercepharma-fiercepharma | About |
/sample | View Sample |
/privacy | Privacy |
http://www.fiercepharma.com/special-reports/top-10-pharma-ceo-salaries-2010 | Top 10 Biopharma CEO salaries of 2010 |
http://www.fiercepharma.com/story/nice-bmss-yervoy-cost-too-darn-high/2011-10-14 | NICE on BMS's Yervoy: The cost is too darn high |
http://www.fiercepharma.com/story/nice-bmss-yervoy-cost-too-darn-high/2011-10-14 | Report |
/feed | Syndicate content |
/story/spains-faes-looks-new-revenue-sources/2011-10-14 | Spain's Faes looks for new revenue sources |
/story/teva-wraps-cephalon-buy-agrees-sell-provigil-copy/2011-10-14 | Teva wraps Cephalon buy, agrees to sell Provigil copy |
/story/obgyn-group-says-kvs-makena-deserves-reimbursement/2011-10-14 | OB/GYN group says KV's Makena deserves reimbursement |
/story/will-nhs-use-avastin-spark-price-cut-lucentis/2011-10-14 | Will NHS use of Avastin spark a price cut for Lucentis? |
/story/nice-bmss-yervoy-cost-too-darn-high/2011-10-14 | NICE on BMS's Yervoy: The cost is too darn high |
/story/faltering-incivek-growth-might-be-ims-data-quirk/2011-10-13 | Faltering Incivek growth might be an IMS data quirk |
/story/private-equity-looks-905m-sale-japans-showa/2011-10-13 | Private equity looks for $905M in sale of Japan's Showa |
/story/kohl-backs-drug-spending-cuts-focused-medicare-part-b/2011-10-13 | Kohl backs drug-spending cuts focused on Medicare Part B |
/story/ipsen-weighs-strategies-russian-growth/2011-10-13 | Ipsen weighs strategies for Russian growth |
/story/weak-cancer-meds-tamiflu-take-bite-out-roche-sales/2011-10-13 | Weak cancer meds, Tamiflu take bite out of Roche sales |
/news | More news |
http://www.fiercepharma.com/story/weak-cancer-meds-tamiflu-take-bite-out-roche-sales/2011-10-13 | Story |
http://www.fiercepharma.com/tags/teva-pharmaceutical | $TEVA |
http://www.fiercepharma.com/tags/baxter | $BAX |
story/spains-faes-aims-asian-drug-launch-otc-selloff-jury-adds-90m-punitive-award/2011-10-14 | Read more >> |
/press_releases/new-data-teva-s-copaxone-and-laquinimod-be-highlighted-ectrimsactrims | New Data on Teva’s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS |
/press_releases/teva-completes-acquisition-cephalon-0 | Teva Completes Acquisition of Cephalon |
/press_releases/k-v-pharmaceutical-comments-acog-and-smfm-information-update-regarding-17-a | K-V PHARMACEUTICAL COMMENTS ON ACOG AND SMFM INFORMATION UPDATE REGARDING 17-ALPHA HYDROXYPROGESTERONE CAPROATE - FDA-APPROVED M |
/press_releases/nice-consults-new-treatment-skin-cancer | NICE consults on a new treatment for skin cancer |
/press_releases/boston-scientific-welcomes-introduction-medical-device-regulatory-improveme | Boston Scientific Welcomes Introduction of Medical Device Regulatory Improvement Act in U.S. Senate |
/press_releases/teva-completes-acquisition-cephalon | Teva Completes Acquisition of Cephalon |
/press-releases | More Press Releases >> |
/press-releases/submit | Submit a press release |
/ | Home |
/signup?sourceform=House-Site_footer-FiercePharma-FiercePharma | Subscribe |
/feed | RSS |
/privacy | Privacy |
/sitemap | Site Map |
/editors | Editors |
http://www.fiercepharma.com/ | FiercePharma |
external links
address | anchor text |
---|---|
http://www.fiercemarkets.com/advertise/publications/ | Advertise |
http://www.fiercebiotech.com/contact | Contact |
http://www.fiercebiotech.com/special-reports | Features |
http://www.fiercebiotech.com/events | Events |
http://www.fiercebiotech.com/ebooks | eBooks |
http://www.fiercebiotech.com/whitepapers | Whitepapers |
http://www.fiercebiotech.com/webinars | Webinars |
http://www.fiercebiotech.com/research | Research |
http://www.fiercebiotech.com/jobs | Jobs |
http://www.jazdlifesciences.com/pharmatech/?utm_source=fiercepharma.com&utm_medium=nav&utm_campaign=partner_integration | Marketplace |
http://www.jazdlifesciences.com/pharmatech/leaf/Drug-Discovery/Clinical-Trial-Management-Software-CTMS.htm?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Clinical Trial Management Software (CTMS) |
http://www.jazdlifesciences.com/pharmatech/leaf/Drug-Discovery/Pharmaceutical-Drug-Development.htm?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Pharmaceutical Drug Development |
http://www.jazdlifesciences.com/pharmatech/leaf/Drug-Discovery/Research-Services/Clinical-Research-Organizations-CRO.htm?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Clinical Research Organizations (CRO) |
http://www.jazdlifesciences.com/pharmatech/leaf/BioPharma/Monoclonal-Antibodies.htm?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Monoclonal Antibodies |
http://www.jazdlifesciences.com/pharmatech/leaf/BioPharma/Polyclonal-Antibodies.htm?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Polyclonal Antibodies |
http://www.jazdlifesciences.com/pharmatech/leaf/Drug-Discovery/Research-Services/Drug-Safety-Information.htm?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Drug Safety Information |
http://www.jazdlifesciences.com/pharmatech?utm_source=fiercepharma&utm_medium=partnermodule&utm_campaign=partner_integration | Evaluate more than 400,000 products >> |
http://www.fiercebiotech.com/jobs/job/36751/director-clinical-research-physician-early-development-ii-job-at-celgene-corporation/ | Director, Clinical Research Physician - Early Development II Job |
http://www.fiercebiotech.com/jobs/job/37801/partner-at-lundbeckfond-ventures/ | Partner |
http://www.fiercebiotech.com/jobs/job/36761/associate-director-global-market-research-job-at-celgene-corporation/ | Associate Director Global Market Research Job |
http://www.fiercebiotech.com/jobs/job/34191/director-clinical-development-at-curis-inc/ | Director, Clinical Development |
http://www.fiercebiotech.com/jobs/job/35891/manager-government-pricing-us-pricing-compliance-job-at-celgene-corporation/ | Manager, Government Pricing (U.S. Pricing Compliance) Job |
http://www.fiercebiotech.com/jobs | More Jobs >> |
http://www.fiercebiotech.com/events/masters-degree-molecular-biotechnology | Master's Degree in Molecular Biotechnology |
http://www.fiercebiotech.com/events/yourencore-bio-pharma-networking-event | YourEncore Bio-Pharma Networking Event |
http://www.fiercebiotech.com/events/pharmabio-congress-oncology-drug-development | Pharma/Bio Congress on Oncology Drug Development |
http://www.fiercebiotech.com/events/next-generation-sequencing-generates-momentum | Next Generation Sequencing Generates Momentum |
http://www.fiercebiotech.com/events | More Events >> |
http://www.twitter.com/fiercepharma | @FiercePharma |
http://www.businessweek.com/news/2011-10-14/faes-plans-asia-sales-push-disposals-as-spain-drug-market-falls.html | News |
http://www.businessweek.com/news/2011-10-13/teva-baxter-must-pay-90-million-punitive-damages-for-propofol.html | Story |
http://www.businessweek.com/ap/financialnews/D9QBGSN00.htm | Item |
http://www.fiercemedicaldevices.com/special-reports/5-devicediagnostic-companies-watch | 5 device/diagnostic companies to watch |
http://www.fiercemedicaldevices.com/special-reports/5-devicediagnostic-companies-watch | Report>> |
http://www.fiercepharmamanufacturing.com/special-reports/top-10-standout-cmos | Top 10 Standout CMOs |
http://www.fiercepharmamanufacturing.com/special-reports/top-10-standout-cmos | See report |
http://www.fiercemedicaldevices.com/special-reports/top-10-medical-device-venture-capital-deals-h1-2011 | Top 10 medical device venture capital deals, H1 2011 |
http://www.fiercemedicaldevices.com/special-reports/top-10-medical-device-venture-capital-deals-h1-2011 | Report>> |
http://www.fiercepharmamanufacturing.com/ | Pharma Manufacturing News |
http://www.fiercepharmamanufacturing.com/story/pain-patch-maker-warned-fda-over-validation-reporting/2011-10-12 | Pain patch maker warned by FDA over validation reporting |
http://www.fiercepharmamanufacturing.com/story/china-assesses-illegal-drug-activities/2011-10-12 | China assesses illegal drug activities |
http://www.fiercepharmamanufacturing.com/story/genzymes-ireland-site-expanded/2011-10-12 | Genzyme's Ireland site expanded |
http://www.fiercepharmamanufacturing.com/story/teva-walloped-163m-hepc-ruling-doc-unfit-trial/2011-10-12 | Teva walloped $163M in hepC ruling, doc 'unfit' for trial |
http://www.fiercepharmamanufacturing.com/story/ex-genzyme-ops-chief-joins-board-bio-start/2011-10-12 | Ex-Genzyme ops chief joins board at bio start-up |
http://www.fiercepharmamanufacturing.com/news | More >> |
http://www.fiercebiotech.com/ | Biotech News |
http://www.fiercebiotech.com/story/epizyme-scores-4m-ongoing-gsk-alliance/2011-10-14 | Epizyme scores $4M in ongoing GSK alliance |
http://www.fiercebiotech.com/story/biotechs-lug-big-risks-option-based-pharma-deals/2011-10-14 | Biotechs lug big risks with option-based pharma deals |
http://www.fiercebiotech.com/story/capstone-therapeutics-axing-78-jobs-hibernation-move/2011-10-14 | Capstone Therapeutics axing 78% of jobs in 'hibernation' move |
http://www.fiercebiotech.com/story/forest-labs-eyes-earlier-assets-drug-pipeline-next-decade-business/2011-10-14 | Forest Labs eyes 'earlier' assets for drug pipeline, next decade of business |
http://www.fiercebiotech.com/story/medivation-chief-amps-rhetoric-ph3-prostate-cancer-drug/2011-10-14 | Medivation chief amps up rhetoric on Ph3 prostate cancer drug |
http://www.fiercebiotech.com/news | More >> |
http://www.fiercebiotechresearch.com/ | Biotech Research News |
http://www.fiercebiotechresearch.com/story/chocolate-miracle-drug/2011-10-11 | Chocolate – the miracle drug? |
http://www.fiercebiotechresearch.com/story/united-therapeutics-wins-45m-deal-oral-antiviral/2011-10-11 | United Therapeutics wins $45M deal for oral antiviral |
http://www.fiercebiotechresearch.com/story/natural-compound-shows-promise-pathway-diabetes-pill/2011-10-11 | Natural compound shows promise as a pathway to diabetes pill |
http://www.fiercebiotechresearch.com/story/diabetes-science-team-finds-negative-regulator-insulin-secretion/2011-10-10 | Diabetes science team finds a "negative regulator" for insulin secretion |
http://www.fiercebiotechresearch.com/story/cloning-tech-used-create-breakthrough-stem-cells-research/2011-10-10 | Cloning tech used to create breakthrough stem cells for research |
http://www.fiercebiotechresearch.com/news | More >> |
http://www.fiercevaccines.com/ | Vaccines News |
http://www.fiercevaccines.com/story/michael-j-fox-foundation-bankrolls-affiris-parkinsons-vaccine/2011-10-13 | Michael J. Fox Foundation bankrolls AFFiRiS Parkinson's vaccine |
http://www.fiercevaccines.com/story/ca-law-lets-girls-make-hpv-vaccination-decisions/2011-10-13 | CA law lets tweens make HPV vaccination decisions |
http://www.fiercevaccines.com/story/inovio-vgx-ink-hep-b-and-c-vaccine-deal/2011-10-13 | Inovio, VGX ink hep B and C vaccine deal |
http://www.fiercevaccines.com/story/hepb-vax-heplisav-posts-positive-ph3-data/2011-10-12 | HepB vax Heplisav posts positive Ph3 data |
http://www.fiercevaccines.com/story/coridon-hsv-2-vaccine-shows-100-efficacy/2011-10-12 | Coridon HSV-2 vaccine shows 100% efficacy |
http://www.fiercevaccines.com/news | More >> |
http://www.drugsafetyalliance.com/safety_budget_white_paper_fierce/ | WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance |
http://www.copperbridgemedia.com/wp-content/themes/CorporateMag/pdf/online_visbility_tourism.pdf?utm_source=White%2BPapers&utm_medium=White%2BPapers%2BSubmission&utm_campaign=White%2BPapers%2BMarketing%2B | Let travelers smell your rich media content |
http://www.copperbridgemedia.com/wp-content/themes/CorporateMag/pdf/FSF.pdf?utm_source=White%2BPapers&utm_medium=White%2BPapers%2BSubmission&utm_campaign=White%2BPapers%2BMarketing%2B | Forum Signature File : solution for Media Marketing |
http://referencecheck.expandable.com | Best Practices: ERP Vendor Reference-Checking |
http://www.otavachemicals.com/index.php?option=com_content&task=view&id=129&Itemid=93 | BRAND-NEW COMPOUNDS |
http://www.bostonhealthcare.com/objects/PDFs/ReimbursementIssueBrief.pdf | The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics |
http://www.fiercebiotech.com/whitepapers | More Whitepapers >> |
http://www.fiercebiotech.com/node/101414 | Trends in mHealth and Telemedicine |
http://www.fiercebiotech.com/node/101413 | The Global Aesthetic Dermatology Market Outlook |
http://www.fiercebiotech.com/node/101412 | Future Directions in Regenerative Medicine |
http://www.fiercebiotech.com/node/98611 | Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive |
http://www.fiercebiotech.com/node/98609 | Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor |
http://www.fiercebiotech.com/node/98608 | Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline |
http://www.fiercebiotech.com/research | More Research Reports >> |
http://www.fiercebiotech.com/mobile | Mobile Edition |
http://www.jazdlifesciences.com/pharmatech/suppliers/?utm_source=fiercepharma.com&utm_medium=footer&utm_campaign=partner_integration | List in Marketplace |
http://www.jazdlifesciences.com/pharmatech/?utm_source=fiercepharma.com&utm_medium=footer&utm_campaign=partner_integration | Supplier in Marketplace |
http://www.fierceenergy.com/ | FierceEnergy |
http://www.fiercesmartgrid.com/ | FierceSmartGrid |
http://www.fiercefinance.com/ | FierceFinance |
http://www.fiercefinanceit.com/ | FierceFinanceIT |
http://www.fiercecomplianceit.com/ | FierceComplianceIT |
http://www.fiercehealthfinance.com/ | FierceHealthFinance |
http://www.fiercehealthit.com/ | FierceHealthIT |
http://www.hospitalimpact.org/ | Hospital Impact |
http://www.fiercemobilehealthcare.com/ | FierceMobileHealthcare |
http://www.fiercehealthpayer.com/ | FierceHealthPayer |
http://www.fiercepracticemanagement.com/ | FiercePracticeManagement |
http://www.fierceemr.com/ | FierceEMR |
http://www.fiercecio.com/ | FierceCIO |
http://www.fiercecontentmanagement.com/ | FierceContentManagement |
http://www.fiercemobileit.com/ | FierceMobileIT |
http://www.fiercegovernmentit.com/ | FierceGovernmentIT |
http://www.fiercegovernment.com/ | FierceGovernment |
http://www.fiercehomelandsecurity.com/ | FierceHomelandSecurity |
http://www.fiercebiotechresearch.com/ | FierceBiotech Research |
http://www.fiercevaccines.com/ | FierceVaccines |
http://www.fiercebiotechit.com/ | FierceBiotechIT |
http://www.fiercepharmamanufacturing.com/ | FiercePharma Manufacturing |
http://www.fiercemedicaldevices.com/ | FierceMedicalDevices |
http://www.fiercedrugdelivery.com/ | FierceDrugDelivery |
http://www.fierceiptv.com/ | FierceIPTV |
http://www.fiercetelecom.com/ | FierceTelecom |
http://www.fierceenterprisecommunications.com/ | FierceEnterpriseCommunications |
http://www.fiercebroadbandwireless.com/ | FierceBroadbandWireless |
http://www.fiercedeveloper.com/ | FierceDeveloper |
http://www.fiercewireless.com/ | FierceWireless |
http://www.fiercewireless.com/europe | FierceWireless:Europe |
http://www.fiercecable.com | FierceCable |